Uploaded October 2025 | Updated September 2026, 3 weeks ago
Ashley describes her and Jameson’s experience of raising a child with a rare disease. After years of advocating for their son, Conner, they were finally offered genetic testing. At the age of 5, Conner was diagnosed with Angelman syndrome, a genetic disorder causing dramatic developmental impairments. While there is no cure for Angelman syndrome, the diagnosis ultimately enabled them to connect with patient support groups that have been invaluable to their family. Microarrays are a key genetic screening tool that can play a critical role in diagnosis when clinicians suspect Angelman syndrome.
Disclaimer: Conner was not tested using an Illumina diagnostic test. This story has been shared as a testimonial of the potential benefits of cytogenetic testing. One person’s experience is not predictive of results in other cases, which may differ based on a variety of factors.
Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
View customer spotlight videos
youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79
View Illumina webinars
youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ
View Illumina support videos
youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM
LinkedIn: linkedin.com/company/illumina
X: https://x.com/illumina
Instagram: instagram.com/illuminainc
Facebook: facebook.com/illuminainc
TikTok: tiktok.com/@illuminainc
Ashley describes her and Jameson’s experience of raising a child with a rare disease. After years of advocating for their son, Conner, they were finally offered genetic testing. At the age of 5, Conner was diagnosed with Angelman syndrome, a genetic disorder causing dramatic developmental impairments. While there is no cure for Angelman syndrome, the diagnosis ultimately enabled them to connect with patient support groups that have been invaluable to their family. Microarrays are a key genetic screening tool that can play a critical role in diagnosis when clinicians suspect Angelman syndrome.
Disclaimer: Conner was not tested using an Illumina diagnostic test. This story has been shared as a testimonial of the potential benefits of cytogenetic testing. One person’s experience is not predictive of results in other cases, which may differ based on a variety of factors.
Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
View customer spotlight videos
youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79
View Illumina webinars
youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ
View Illumina support videos
youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM
LinkedIn: linkedin.com/company/illumina
X: https://x.com/illumina
Instagram: instagram.com/illuminainc
Facebook: facebook.com/illuminainc
TikTok: tiktok.com/@illuminainc
